Introduction: Most commonly ureterovaginal fistula occurs due to surgical injury inflicted to the distal ureter and because of gynaecological procedures. Open surgical repair is a standard procedure and commonly involves ureteroneocystostomy. Methods: We retrospectively reviewed data of 9 patients, who underwent laparoscopic extravesical Lich-Gregoir ureteroneocystostomy using the psoas hitch procedure for ureterovaginal fistulas following hysterectomy during the period December 2012-August 2014. Transperitoneal laparoscopic ureteroneocystostomy was performed in all cases. Results: The mean operative time was 212 min (range 170-310) and estimated blood loss was 108 ml (range 70-150). Average hospital stay was 5.7 days. Follow-up time was from 6 to 26 months. Postoperative intravenous urography was done after 3 months, which showed patent anastomosis in 8 patients except for 1 patient who had nonvisualization of the ipsilateral renal moiety. Voiding cystogram done at 3 months showed no leakage in all patients. In the postoperative period, 1 patient had recurrent ipsilateral pyelonephritis 2 weeks after surgery, while another patient had febrile UTI. Apart from these no major complications were observed. Conclusion: Laparoscopic ureteroneocystostomy with psoas hitch can be performed safely with a success rate compared to that of open surgery but with less morbidity and quick convalescence.

1.
Elliott SP, McAninch JW: Ureteral injuries: external and iatrogenic. Urol Clin North Am 2006;33:55-66, vi.
2.
Moawad G, von Walter Gonzalez A: Management of urinary tract injuries in minimally invasive gynecologic surgery. Postgrad Obstet Gynecol 2013;33:1-7.
3.
Selzman AA, Spirnak JP: Iatrogenic ureteral injuries: a 20-year experience in treating 165 injuries. J Urol 1996;155:878-881.
4.
Mandal AK, Sharma SK, Vaidyanathan S, Goswami AK: Ureterovaginal fistula: summary of 18 years' experience. Br J Urol 1990;65:453-456.
5.
De Cicco C, Ussia A, Koninckx PR: Laparoscopic ureteral repair in gynaecological surgery. Curr Opin Obstet Gynecol 2011;23:296-300.
6.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
7.
Singh O, Gupta SS, Mathur RK: Urogenital fistulas in women: 5-year experience at a single center. Urol J 2010;7:35-39.
8.
Härkki-Sirén P, Sjöberg J, Tiitinen A: Urinary tract injuries after hysterectomy. Obstet Gynecol 1998;92:113-118.
9.
Wu HH, Yang PY, Yeh GP, Chou PH, Hsu JC, Lin KC: The detection of ureteral injuries after hysterectomy. J Minim Invasive Gynecol 2006;13:403-408.
10.
Léonard F, Fotso A, Borghese B, Chopin N, Foulot H, Chapron C: Ureteral complications from laparoscopic hysterectomy indicated for benign uterine pathologies: a 13-year experience in a continuous series of 1300 patients. Hum Reprod 2007;22:2006-2011.
11.
Park JH, Park JW, Song K, Jo MK: Ureteral injury in gynecologic surgery: a 5-year review in a community hospital. Korean J Urol 2012;53:120-125.
12.
Shaw J, Tunitsky-Bitton E, Barber MD, Jelovsek JE: Ureterovaginal fistula: a case series. Int Urogynecol J 2014;25:615-621.
13.
Mahendran HA, Praveen S, Ho C, Goh EH, Tan GH, Zuklifli MZ: Iatrogenic ureter injuries: eleven years experience in a tertiary hospital. Med J Malaysia 2012;67:169-172.
14.
Yang C, Jones L, Rivera ME, VerLee GT, Deane LA: Robotic-assisted ureteral reimplantation with Boari flap and psoas hitch: a single-institution experience. J Laparoendosc Adv Surg Tech A 2011;21:829-833.
15.
Kozinn SI, Canes D, Sorcini A, Moinzadeh A: Robotic versus open distal ureteral reconstruction and reimplantation for benign stricture disease. J Endourol 2012;26:147-151.
16.
Callewaert PR, Biallosterski BT, Rahnama'i MS, Van Kerrebroeck PE: Robotic extravesical anti-reflux operations in complex cases: technical considerations and preliminary results. Urol Int 2012;88:6-11.
17.
Ehrlich RM, Gershman A, Fuchs G: Laparoscopic vesicoureteroplasty in children: initial case reports. Urology 1994;43:255-261.
18.
Reddy PK, Evans RM: Laparoscopic ureteroneocystostomy. J Urol 1994;152:2057-2059.
19.
Modi P, Gupta R, Rizvi SJ: Laparoscopic ureteroneocystostomy and psoas hitch for post-hysterectomy ureterovaginal fistula. J Urol 2008;180:615-617.
20.
Gupta A, Bansal P, Bera MK, Kundu AK, Kalra A, Vijay MK, Dutta A, Singla S, Tiwari P: Laparoscopic ureteroneocystostomy for management of lower ureteric strictures. Urol Ann 2009;1:47-51.
21.
Rassweiler JJ, Gözen AS, Erdogru T, Sugiono M, Teber D: Ureteral reimplantation for management of ureteral strictures: a retrospective comparison of laparoscopic and open techniques. Eur Urol 2007;51:512-522; discussion 522-523.
22.
Gözen AS, Cresswell J, Canda AE, Ganta S, Rassweiler J, Teber D: Laparoscopic ureteral reimplantation: prospective evaluation of medium-term results and current developments. World J Urol 2010;28:221-226.
23.
Puntambekar S, Palep RJ, Gurjar AM, Sathe RM, Talaulikar AG, Agarwal GA, Kashyap M: Laparoscopic ureteroneocystostomy with psoas hitch. J Minim Invasive Gynecol 2006;13:302-305.
24.
Symons S, Kurien A, Desai M: Laparoscopic ureteral reimplantation: a single center experience and literature review. J Endourol 2009;23:269-274.
25.
Pompeo A, Molina WR, Sehrt D, Tobias-Machado M, Mariano Costa RM, Pompeo AC, Kim FJ: Laparoscopic ureteroneocystostomy for ureteral injuries after hysterectomy. JSLS 2013;17:121-125.
26.
Sharma S, Rizvi SJ, Bethur SS, Bansal J, Qadri SJ, Modi P: Laparoscopic repair of urogenital fistulae: a single centre experience. J Minim Access Surg 2014;10:180-184.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.